Celera Genomics to Webcast Its Analyst and Investor Meeting on Thursday, June 22, 2006; Celera to Present Its Strategy for Growth and Provide Outlook for Fiscal 2007.

ROCKVILLE, Md. -- Celera Genomics Group (NYSE:CRA), an Applera Corporation business, announced today that it will webcast its Analyst & Investor Meeting in New York, NY, on Thursday, June 22, 2006. The live webcast is scheduled to begin at 9:00 a.m. Eastern Time. At the meeting, Celera's senior management will discuss the strategy for the business following the integration of Celera Diagnostics into Celera Genomics and update the investment community on the status of key products and development programs. Celera management will also present its strategy for growth across all parts of the business, and as part of this presentation, management will provide its financial and business outlook for the business for fiscal 2007.

Interested parties may access the live webcast and replay by visiting the Investors & Media section of either the Celera Genomics website at www.celera.com or the Applera website at www.applera.com. It is suggested that participants access the webcast 15 minutes before the start of the live broadcast. The webcast replay will be archived until September 22, 2006 on the Presentations page of the Investors & Media section of each website.

About Celera Genomics and Applera Corporation

Applera Corporation consists of two operating groups. The Celera Genomics Group uses proprietary genomics and proteomics discovery platforms to develop molecular diagnostic products and to identify and validate novel drug targets. Celera maintains a strategic alliance in molecular diagnostics with Abbott. In addition, Celera is developing new molecular diagnostic and pharmacogenomic assays outside of its alliance with Abbott. Therapeutic antibodies against Celera-discovered drug targets are being advanced through strategic partnerships. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems' products also serve the needs of some markets outside of life science research, which we refer to as "applied markets," such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, for example in food and the environment. Applied Biosystems is headquartered in Foster City, CA, and reported sales of nearly $1.8 billion during fiscal 2005. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800-762-6923. Information about Celera Genomics is available at http://www.celera.com.